<DOC>
	<DOCNO>NCT00977886</DOCNO>
	<brief_summary>The purpose trial study safety tolerability repeat oral dos ELB353 , evaluate plasma level ELB353 study effect substance mediate inflammation .</brief_summary>
	<brief_title>Safety Pharmacokinetics ELB353 Healthy Men</brief_title>
	<detailed_description />
	<criteria>Healthy Concomitant medication Concomitant disease</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2010</verification_date>
</DOC>